vs
BALCHEM CORP（BCPC）与ONESPAWORLD HOLDINGS Ltd（OSW）财务数据对比。点击上方公司名可切换其他公司
BALCHEM CORP的季度营收约是ONESPAWORLD HOLDINGS Ltd的1.1倍（$263.6M vs $242.1M），BALCHEM CORP净利率更高（14.9% vs 5.0%，领先9.9%），ONESPAWORLD HOLDINGS Ltd同比增速更快（11.5% vs 9.8%），过去两年ONESPAWORLD HOLDINGS Ltd的营收复合增速更高（7.1% vs 4.9%）
Balchem Corp是一家全球特种化学品与营养原料供应商，核心业务覆盖人类营养、动物保健、制药、工业应用四大领域，为北美、欧洲、亚太等地区的客户提供定制化专用原料产品。
BCPC vs OSW — 直观对比
营收规模更大
BCPC
是对方的1.1倍
$242.1M
营收增速更快
OSW
高出1.6%
9.8%
净利率更高
BCPC
高出9.9%
5.0%
两年增速更快
OSW
近两年复合增速
4.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $263.6M | $242.1M |
| 净利润 | $39.2M | $12.1M |
| 毛利率 | 35.6% | — |
| 营业利润率 | 19.8% | 6.8% |
| 净利率 | 14.9% | 5.0% |
| 营收同比 | 9.8% | 11.5% |
| 净利润同比 | 16.8% | -16.2% |
| 每股收益（稀释后） | $1.21 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCPCOSW
| Q4 25 | $263.6M | $242.1M | ||
| Q3 25 | $267.6M | $258.5M | ||
| Q2 25 | $255.5M | $240.7M | ||
| Q1 25 | $250.5M | $219.6M | ||
| Q4 24 | $240.0M | $217.2M | ||
| Q3 24 | $239.9M | $241.7M | ||
| Q2 24 | $234.1M | $224.9M | ||
| Q1 24 | $239.7M | $211.2M |
净利润BCPCOSW
| Q4 25 | $39.2M | $12.1M | ||
| Q3 25 | $40.3M | $24.3M | ||
| Q2 25 | $38.3M | $19.9M | ||
| Q1 25 | $37.1M | $15.3M | ||
| Q4 24 | $33.6M | $14.4M | ||
| Q3 24 | $33.8M | $21.6M | ||
| Q2 24 | $32.1M | $15.8M | ||
| Q1 24 | $29.0M | $21.2M |
毛利率BCPCOSW
| Q4 25 | 35.6% | — | ||
| Q3 25 | 35.7% | — | ||
| Q2 25 | 36.4% | — | ||
| Q1 25 | 35.2% | — | ||
| Q4 24 | 36.0% | — | ||
| Q3 24 | 35.6% | — | ||
| Q2 24 | 35.5% | — | ||
| Q1 24 | 34.0% | — |
营业利润率BCPCOSW
| Q4 25 | 19.8% | 6.8% | ||
| Q3 25 | 20.4% | 10.2% | ||
| Q2 25 | 20.1% | 9.2% | ||
| Q1 25 | 20.4% | 7.7% | ||
| Q4 24 | 19.8% | 7.9% | ||
| Q3 24 | 20.0% | 10.3% | ||
| Q2 24 | 19.6% | 8.4% | ||
| Q1 24 | 17.4% | 8.0% |
净利率BCPCOSW
| Q4 25 | 14.9% | 5.0% | ||
| Q3 25 | 15.1% | 9.4% | ||
| Q2 25 | 15.0% | 8.3% | ||
| Q1 25 | 14.8% | 7.0% | ||
| Q4 24 | 14.0% | 6.6% | ||
| Q3 24 | 14.1% | 8.9% | ||
| Q2 24 | 13.7% | 7.0% | ||
| Q1 24 | 12.1% | 10.0% |
每股收益（稀释后）BCPCOSW
| Q4 25 | $1.21 | $0.12 | ||
| Q3 25 | $1.24 | $0.23 | ||
| Q2 25 | $1.17 | $0.19 | ||
| Q1 25 | $1.13 | $0.15 | ||
| Q4 24 | $1.03 | $0.13 | ||
| Q3 24 | $1.03 | $0.20 | ||
| Q2 24 | $0.98 | $0.15 | ||
| Q1 24 | $0.89 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $74.6M | $16.3M |
| 总债务越低越好 | — | $84.0M |
| 股东权益账面价值 | $1.3B | $542.6M |
| 总资产 | $1.7B | $707.1M |
| 负债/权益比越低杠杆越低 | — | 0.15× |
8季度趋势，按日历期对齐
现金及短期投资BCPCOSW
| Q4 25 | $74.6M | $16.3M | ||
| Q3 25 | $65.1M | $29.6M | ||
| Q2 25 | $65.4M | $35.0M | ||
| Q1 25 | $49.9M | $22.6M | ||
| Q4 24 | $49.5M | $57.4M | ||
| Q3 24 | $73.7M | $48.8M | ||
| Q2 24 | $63.7M | $62.5M | ||
| Q1 24 | $60.3M | $65.4M |
总债务BCPCOSW
| Q4 25 | — | $84.0M | ||
| Q3 25 | — | $85.2M | ||
| Q2 25 | — | $96.2M | ||
| Q1 25 | — | $97.4M | ||
| Q4 24 | — | $98.6M | ||
| Q3 24 | — | $98.7M | ||
| Q2 24 | — | $123.8M | ||
| Q1 24 | — | $138.6M |
股东权益BCPCOSW
| Q4 25 | $1.3B | $542.6M | ||
| Q3 25 | $1.3B | $552.8M | ||
| Q2 25 | $1.3B | $548.3M | ||
| Q1 25 | $1.2B | $530.6M | ||
| Q4 24 | $1.1B | $554.5M | ||
| Q3 24 | $1.2B | $540.1M | ||
| Q2 24 | $1.1B | $532.7M | ||
| Q1 24 | $1.1B | $515.5M |
总资产BCPCOSW
| Q4 25 | $1.7B | $707.1M | ||
| Q3 25 | $1.7B | $732.6M | ||
| Q2 25 | $1.7B | $731.8M | ||
| Q1 25 | $1.6B | $708.7M | ||
| Q4 24 | $1.6B | $746.4M | ||
| Q3 24 | $1.6B | $734.0M | ||
| Q2 24 | $1.6B | $756.8M | ||
| Q1 24 | $1.6B | $763.6M |
负债/权益比BCPCOSW
| Q4 25 | — | 0.15× | ||
| Q3 25 | — | 0.15× | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.18× | ||
| Q4 24 | — | 0.18× | ||
| Q3 24 | — | 0.18× | ||
| Q2 24 | — | 0.23× | ||
| Q1 24 | — | 0.27× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $67.3M | $20.0M |
| 自由现金流经营现金流 - 资本支出 | — | $14.9M |
| 自由现金流率自由现金流/营收 | — | 6.2% |
| 资本支出强度资本支出/营收 | — | 2.1% |
| 现金转化率经营现金流/净利润 | 1.72× | 1.65× |
| 过去12个月自由现金流最近4个季度 | — | $68.4M |
8季度趋势，按日历期对齐
经营现金流BCPCOSW
| Q4 25 | $67.3M | $20.0M | ||
| Q3 25 | $65.6M | $33.2M | ||
| Q2 25 | $47.3M | $20.3M | ||
| Q1 25 | $36.5M | $10.1M | ||
| Q4 24 | $52.3M | $16.6M | ||
| Q3 24 | $51.3M | $28.6M | ||
| Q2 24 | $45.0M | $18.7M | ||
| Q1 24 | $33.4M | $15.0M |
自由现金流BCPCOSW
| Q4 25 | — | $14.9M | ||
| Q3 25 | — | $27.6M | ||
| Q2 25 | — | $17.6M | ||
| Q1 25 | — | $8.4M | ||
| Q4 24 | — | $13.2M | ||
| Q3 24 | — | $27.5M | ||
| Q2 24 | — | $17.6M | ||
| Q1 24 | — | $13.7M |
自由现金流率BCPCOSW
| Q4 25 | — | 6.2% | ||
| Q3 25 | — | 10.7% | ||
| Q2 25 | — | 7.3% | ||
| Q1 25 | — | 3.8% | ||
| Q4 24 | — | 6.1% | ||
| Q3 24 | — | 11.4% | ||
| Q2 24 | — | 7.8% | ||
| Q1 24 | — | 6.5% |
资本支出强度BCPCOSW
| Q4 25 | — | 2.1% | ||
| Q3 25 | — | 2.2% | ||
| Q2 25 | — | 1.1% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | — | 1.5% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | 0.5% | ||
| Q1 24 | — | 0.6% |
现金转化率BCPCOSW
| Q4 25 | 1.72× | 1.65× | ||
| Q3 25 | 1.63× | 1.36× | ||
| Q2 25 | 1.23× | 1.02× | ||
| Q1 25 | 0.98× | 0.66× | ||
| Q4 24 | 1.56× | 1.15× | ||
| Q3 24 | 1.52× | 1.33× | ||
| Q2 24 | 1.40× | 1.19× | ||
| Q1 24 | 1.15× | 0.71× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
OSW
| Services | $197.3M | 82% |
| Products | $44.8M | 18% |
